Prodromal biomarkers in fatal familial insomnia: a longitudinal study in humans and mice.

Coordinator: Roberto Chiesa, Istituto di Ricerche Farmacologiche Mario Negri, Italy.
Project pitch by Roberto Chiesa.

Early Diagnosis of Alzheimer’s Disease by Immune Profiling of Cytotoxic Lymphocytes and Recording of Sleep Disturbances.

Coordinator: Holger Fröhlich, Fraunhofer Gesellschaft e.V., Germany.
Project pitch by Holger Fröhlich.

Prediagnostic early synaptic disturbances in neurodegenerative diseases.

Coordinator: Annakaisa Haapasalo, University of Eastern Finland.
Project pitch by Annakaisa Haapasalo.

Early stage neuroimaging and behavioral biomarkers of PD progression and underlying mechanisms.

Coordinator: Nikolaus Weiskopf, Max Planck Gesellschaft, Germany.
Project pitch by Gilles VandeWalle.

MIcroglial early Neuroinflammatory Dysfunction in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis due to C9orf72 repeat Expansions.

Coordinator: John van Swieten, Erasmus MC, Netherlands.
Project pitch by John van Swieten.

Human brain clearance imaging (HBCI): a window on physiological disturbances in the pre-diagnostic phase of neurodegenerative diseases.

Coordinator: Matthias van Osch, Academisch Ziekenhuis Leiden, Netherlands.
Project pitch by Matthias van Osch.

Leveraging medical records to identify patients at risk of neurodegenerative disease.

Coordinator: Stanley Durrleman, Paris Brain Institute - Institut du cerveau (ICM), France.
Project pitch by Stanley Durrleman.

COgNiTive propagation in pRodrOmaL Parkinson’s disease.

Coordinator: Rick Helmich, Stichting Radboud universitair medisch centrum, Netherlands.
Project pitch by Rick Helmich.

Presymptomatic synaptic disorders in Alzheimer’s disease.

Coordinator: Christophe Mulle, CNRS, France.
Project pitch by Christophe Mulle.

A premotor disease signature for ALS.

Coordinator: Paul Lingor, Klinikum rechts der Isar der Technischen Universität München, Germany.
Project pitch by Paul Lingor.

Early indicators of nervous system dysfunction in gut-first and brain-first animal models of Parkinson’s Disease.

Coordinator: Nathalie van den Berge, Aarhus University, Denmark.
Project pitch by Nathalie Van Den Berge.

Risk factors and markers for early detection of Alzheimer’s Disease: focus on early-life adversity, inflammation and lipid mediators.

Coordinator: Sarah Spencer, RMIT University, Australia.
Project pitch by Aniko Korosi.

TACKLing the challenges of PREsymptomatic sporadic Dementia.

Coordinator: Mario Masellis, Sunnybrook Health Sciences Centre, University of Toronto, Canada.
Project pitch by Usman Saeed.